Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, United Kingdom; Division of Brain Sciences, Department of Medicine, Hammersmith Campus, Imperial College London, London, United Kingdom.
Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
J Stroke Cerebrovasc Dis. 2019 Oct;28(10):104277. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.035. Epub 2019 Jul 18.
Transcatheter Aortic Valve Implantation (TAVI) is an increasingly treatment modality for severe aortic stenosis, which is associated with a considerable peri-procedural risk of stroke. To date, the clinical safety and efficacy of Tissue plasminogen activator (tPA) and mechanical thrombectomy in stroke post-TAVI is not established. We describe 2 cases of patients with stroke after TAVI who received tPA therapy and mechanical thrombectomy.
经导管主动脉瓣植入术（TAVI）是一种治疗严重主动脉瓣狭窄的方法，与围手术期中风风险较高有关。迄今为止，组织型纤溶酶原激活剂（tPA）和机械血栓切除术在 TAVI 后中风中的临床安全性和疗效尚未确定。我们描述了 2 例 TAVI 后中风患者接受 tPA 治疗和机械血栓切除术的病例。
